Arrhythmias & electrophysiology

Renal Outcomes of Rhythm Control in Patients Recently Diagnosed With Atrial Fibrillation

JACC Clin ElectrophysiolPublished Retrospective cohort study

Authors' conclusion

Among patients with AF and CKD, early rhythm control was associated with lower risks of adverse renal outcomes than rate control was.

Study context

Population
Patients recently diagnosed with atrial fibrillation (AF) with baseline estimated glomerular filtration rate (eGFR) data, Korea, 2005–2015; median age 62 years, 32.7% female2,213 (10.6%) with eGFR <60
Participants
20,886 participants
Exposure
Early rhythm control vs rate control
Outcome
Primary composite outcome, by CKD status
Methodological detailspropensity overlap weighting, Korean National Health Insurance Service database
  • Propensity overlap weighting
  • Korean National Health Insurance Service database

Main finding

As reported in the abstract

Rhythm control

Significant chronic kidney disease (CKD)
2.77 per 100 person-years
No significant CKD
3.41 per 100 person-years

Rate control

Significant CKD
3.92 per 100 person-years
No significant CKD
3.21 per 100 person-years

Significant chronic kidney disease (CKD)

Rhythm control2.77 per 100 person-years
Rate control3.92 per 100 person-years

No significant CKD

Rhythm control3.41 per 100 person-years
Rate control3.21 per 100 person-years
Rhythm control vs Rate controlWeighted hazard ratio (95% CI)
Significant CKD
0.70(0.52–0.95)
No significant CKD
1.06(0.96–1.18)

Observational data: associations, not effects.

Safety

Safety outcomes

No differences between rhythm and rate control, with or without significant CKD

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Renal Outcomes of Rhythm Control in Patients Recently Diagnosed With Atrial Fibrillation. JACC Clin Electrophysiol. Published 4 September 2024. doi:10.1016/j.jacep.2024.07.007

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.